{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:32:22Z","timestamp":1777419142242,"version":"3.51.4"},"reference-count":69,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate the safety and efficacy of current pharmacotherapeutic options for weight loss in overweight adolescents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>Literature was obtained through MEDLINE Ovid (1996\u2013April 2007) and EMBASE Drugs and Pharmacology (1991\u20132nd quarter 2007) searches and a bibliographic review of published articles. Key words included adolescents, overweight, obesity, anti-obesity agents, drug therapy, orlistat, sibutramine, and metformin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection and Data Extraction:<\/jats:title>\n                    <jats:p>All studies published in the English language that evaluated the use of pharmacotherapy for the treatment of overweight adolescents were critically analyzed; pertinent articles were selected for this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>\n                      Orlistat has been approved for use in adolescents between the ages of 12 and 16 years. The most frequently reported adverse effects of orlistat were gastrointestinal; reduced concentrations of fat-soluble vitamins were also observed. Of the 6 clinical trials published, 5 have shown statistically significant reductions in body mass index {BMI) from baseline, ranging from 0.55 to 4.09 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ; one small trial failed to demonstrate significant weight reduction compared with placebo. Sibutramine has also been evaluated for use in overweight adolescents in 6 trials. Trials demonstrated a statistically significant reduction in BMI up to 5.6 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      (from baseline). Of concern is evidence indicating that sibutramine therapy may be associated with elevated blood pressure, increased pulse rate, depression, and suicidal ideations. Lastly, metformin has recently been evaluated for weight loss in overweight adolescents; small, short-term trials demonstrate modest reductions in weight and BMI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Orlistat has been proven both safe and effective for weight reduction in overweight adolescents. Sibutramine has also been proven effective in reducing weight in this population; however, the potential for severe adverse effects requires further investigation. Metformin has demonstrated promising results in small trials; its role in the treatment of overweight adolescents will remain investigational until further research is conducted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1k022","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T20:34:09Z","timestamp":1185309249000},"page":"1445-1455","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacotherapeutic Options for Overweight Adolescents"],"prefix":"10.1177","volume":"41","author":[{"given":"Kaelen C","family":"Dunican","sequence":"first","affiliation":[{"name":"Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences-Worcester\/Manchester, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia R","family":"Desilets","sequence":"additional","affiliation":[{"name":"Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences-Worcester\/Manchester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie K","family":"Montalbano","sequence":"additional","affiliation":[{"name":"Massachusetts College of Pharmacy and Health Sciences-Worcester\/Manchester"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2007,9,1]]},"reference":[{"key":"bibr1-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.14.1728"},{"key":"bibr2-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(03)00074-4"},{"key":"bibr3-aph.1K022","unstructured":"National Institutes of Health, National Heart, Lung and Blood Institute, North American Association for the Study of Obesity. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication 00-4084, October 2000 (online). www.nhlbi.nih.gov\/guidelines\/obesity\/prctgd_c.pdf (accessed 2007 Apr 28)."},{"key":"bibr4-aph.1K022","unstructured":"BMI\u2014body mass index: about BMI for children and teens. CDC. www.cdc.gov\/nccdphp\/dnpa\/bmi\/childrens_BMI\/about_childrens_BMI.htm (accessed 2007 Apr 28)."},{"key":"bibr5-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.1549"},{"key":"bibr6-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709253371301"},{"key":"bibr7-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021442"},{"key":"bibr8-aph.1K022","unstructured":"The Surgeon General's call to action to prevent and decrease overweight and obesity. www.surgeongeneral.gov\/topics\/obesity\/calltoaction\/fact_adolescents.htm (accessed 2007 Apr 28)."},{"key":"bibr9-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.6.1175"},{"key":"bibr10-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.S2.518"},{"key":"bibr11-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800852"},{"key":"bibr12-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031049"},{"key":"bibr13-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.157.8.821"},{"key":"bibr14-aph.1K022","first-page":"2591","volume":"69","author":"Fowler-Brown A","year":"2004","journal-title":"Am Fam Physician"},{"key":"bibr15-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2004.151"},{"key":"bibr16-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70356-4"},{"key":"bibr17-aph.1K022","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.9.920"},{"key":"bibr18-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-7560(200001\/02)16:1<2::AID-DMRR75>3.0.CO;2-G"},{"key":"bibr19-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2004.206"},{"key":"bibr20-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802783"},{"key":"bibr21-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.86"},{"key":"bibr22-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2001.71"},{"key":"bibr23-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.142"},{"key":"bibr24-aph.1K022","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565120-00008"},{"key":"bibr25-aph.1K022","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1092"},{"key":"bibr26-aph.1K022","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1083"},{"key":"bibr27-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.14.1820"},{"key":"bibr28-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.4.e55"},{"key":"bibr29-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2001.28078"},{"key":"bibr30-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0241"},{"key":"bibr31-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803453"},{"key":"bibr32-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000238099.36998.6b"},{"key":"bibr33-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66374-X"},{"key":"bibr34-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.7.761"},{"key":"bibr35-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802475"},{"key":"bibr36-aph.1K022","volume-title":"Product information. Meridia (sibutramine hydrochloride monohydrate) capsules","year":"2006"},{"key":"bibr37-aph.1K022","volume-title":"Product information. Xenical (orlistat) capsules","year":"2005"},{"key":"bibr38-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04034.x"},{"key":"bibr39-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922007543"},{"key":"bibr40-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2005.07.010"},{"key":"bibr41-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2000.8"},{"key":"bibr42-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11509-4"},{"key":"bibr43-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.235"},{"key":"bibr44-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801128"},{"key":"bibr45-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.9.2.160"},{"key":"bibr46-aph.1K022","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.155"},{"key":"bibr47-aph.1K022","unstructured":"FDA CDER Division of Metabolic and Endocrine Drug Products (HFD-510). Clinical review for NDA 20-766\/S018. www.fda.gov\/cder\/foi\/esum\/2003\/20766se5-018_Orlistat_BPCA_CLINICAL_ltr.pdf (accessed 2007 Jan 8)."},{"key":"bibr48-aph.1K022","unstructured":"FDA approves orlistat for over-the-counter use. www.fda.gov\/bbs\/topics\/NEWS\/2007\/NEW01557.html (accessed 2007 Apr 28)."},{"key":"bibr49-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.87"},{"key":"bibr50-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2004.17.3.307"},{"key":"bibr51-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2003.tb00596.x"},{"key":"bibr52-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-004-1534-6"},{"key":"bibr53-aph.1K022","doi-asserted-by":"publisher","DOI":"10.4158\/EP.12.1.18"},{"key":"bibr54-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.23.2873"},{"key":"bibr55-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2003.10719318"},{"key":"bibr56-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.11.814.33627"},{"key":"bibr57-aph.1K022","first-page":"505","volume":"50","author":"Smith IG","year":"2001","journal-title":"J Fam Pract"},{"key":"bibr58-aph.1K022","first-page":"369","volume":"10","author":"Porter JA","year":"2004","journal-title":"Am J Manag Care"},{"key":"bibr59-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050156"},{"key":"bibr60-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.11.1331"},{"key":"bibr61-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03491-7"},{"key":"bibr62-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.14.1805"},{"key":"bibr63-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0263"},{"key":"bibr64-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1007\/BF02849958"},{"key":"bibr65-aph.1K022","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-2-200607180-00005"},{"key":"bibr66-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.05.008"},{"key":"bibr67-aph.1K022","first-page":"30","volume":"8","author":"Reisler G","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"bibr68-aph.1K022","unstructured":"Beaston P. Clinical review for NDA 20-632,SE5-021. www.fda.gov\/cder\/foi\/esum\/2005\/020632s021_sibutramine_hydrochloride_clinical_BPCA.pdf (accessed 2007 Apr 28)."},{"key":"bibr69-aph.1K022","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.e29"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1K022","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1K022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:09:34Z","timestamp":1777374574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1K022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1345\/aph.1K022"],"URL":"https:\/\/doi.org\/10.1345\/aph.1k022","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}